NO175350C - Fremgangsmåte for fremstilling av et topisk krempreparat for behandling av betennelse - Google Patents

Fremgangsmåte for fremstilling av et topisk krempreparat for behandling av betennelse

Info

Publication number
NO175350C
NO175350C NO882417A NO882417A NO175350C NO 175350 C NO175350 C NO 175350C NO 882417 A NO882417 A NO 882417A NO 882417 A NO882417 A NO 882417A NO 175350 C NO175350 C NO 175350C
Authority
NO
Norway
Prior art keywords
preparation
inflammation
treatment
topical cream
alpha
Prior art date
Application number
NO882417A
Other languages
English (en)
Other versions
NO175350B (no
NO882417L (no
NO882417D0 (no
Inventor
Farah Joseph Munayyer
Joel August Sequeira
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Publication of NO882417L publication Critical patent/NO882417L/no
Publication of NO882417D0 publication Critical patent/NO882417D0/no
Publication of NO175350B publication Critical patent/NO175350B/no
Publication of NO175350C publication Critical patent/NO175350C/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Peptides Or Proteins (AREA)
  • Semiconductor Memories (AREA)
  • Insulated Gate Type Field-Effect Transistor (AREA)
NO882417A 1986-10-02 1988-06-01 Fremgangsmåte for fremstilling av et topisk krempreparat for behandling av betennelse NO175350C (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US06/914,227 US4808610A (en) 1986-10-02 1986-10-02 Mometasone furoate anti-inflammatory cream composition using hexylene glycol
PCT/US1987/002470 WO1988002257A1 (en) 1986-10-02 1987-10-01 Anti-inflammatory cream composition

Publications (4)

Publication Number Publication Date
NO882417L NO882417L (no) 1988-06-01
NO882417D0 NO882417D0 (no) 1988-06-01
NO175350B NO175350B (no) 1994-06-27
NO175350C true NO175350C (no) 1994-10-05

Family

ID=25434063

Family Applications (1)

Application Number Title Priority Date Filing Date
NO882417A NO175350C (no) 1986-10-02 1988-06-01 Fremgangsmåte for fremstilling av et topisk krempreparat for behandling av betennelse

Country Status (22)

Country Link
US (1) US4808610A (no)
EP (2) EP0262681B1 (no)
JP (1) JPH0643317B2 (no)
KR (2) KR930010585B1 (no)
AT (1) ATE62815T1 (no)
AU (1) AU603837B2 (no)
CA (1) CA1294877C (no)
DE (1) DE3769568D1 (no)
DK (1) DK174790B1 (no)
ES (1) ES2038643T3 (no)
FI (1) FI100047B (no)
GR (1) GR3002086T3 (no)
HK (1) HK102593A (no)
IE (1) IE60492B1 (no)
IL (1) IL84055A (no)
MX (1) MX9203395A (no)
NO (1) NO175350C (no)
NZ (1) NZ222020A (no)
OA (1) OA09034A (no)
PH (1) PH23440A (no)
WO (1) WO1988002257A1 (no)
ZA (1) ZA877401B (no)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3850834T2 (de) * 1987-09-23 1995-03-30 Oreal Hautbehandlungsmittel als Aerosolschaum, das Vaseline enthält.
US5223340A (en) * 1989-04-20 1993-06-29 Peach State Labs, Inc. Stain resistant polyamide fibers
US5057500A (en) * 1990-02-12 1991-10-15 Dermatologic Research Corporation Treatment of pruritis with esters and amides
IL99437A (en) 1990-09-10 1995-05-29 Schering Corp Mumtazone Foroat Monohydrate, its preparation method and medicinal preparations
US6127353A (en) * 1991-09-06 2000-10-03 Schering Corporation Mometasone furoate monohydrate, process for making same and pharmaceutical compositions
US5407678A (en) * 1993-09-01 1995-04-18 Chesebrough-Pond's Usa Co., Division Of Conopco, Inc. Petroleum jelly cream
DE69433923T2 (de) * 1993-12-21 2005-07-21 Schering Corp. Salbe enthaltend mometason-furoat und salicylsäure zur topischen behandlung von psoriasis
US5696105A (en) * 1996-03-14 1997-12-09 Hackler; Walter A. Antifungal nail composition
US6515016B2 (en) * 1996-12-02 2003-02-04 Angiotech Pharmaceuticals, Inc. Composition and methods of paclitaxel for treating psoriasis
US6495579B1 (en) 1996-12-02 2002-12-17 Angiotech Pharmaceuticals, Inc. Method for treating multiple sclerosis
AU5303899A (en) * 1998-08-26 2000-03-21 Shionogi & Co., Ltd. Anti-inflammatory ointments
FR2787025B1 (fr) * 1998-12-14 2002-10-11 Oreal Composition sous forme d'emulsion h/e a forte teneur en cire et ses utilisations dans les domaines cosmetique et dermatologique
EP1478031A4 (en) 2002-02-19 2008-12-03 Hoya Corp LIGHT EMISSION ELEMENT OF THE FIELD EFFECT TRANSISTOR TYPE
WO2004105686A2 (en) 2003-05-23 2004-12-09 Taro Pharmaceuticals U.S.A., Inc. Novel topical steroid cream formulations
DE102006034883A1 (de) * 2006-07-25 2008-01-31 Hermal Kurt Herrmann Gmbh & Co. Ohg Pharmazeutische Zusammensetzung enthaltend Mometasonfuroat
EP2120868A4 (en) * 2007-04-11 2010-08-25 Perrigo Israel Phamaceuticals LOW-DOSED MOMETASON FORMULATIONS
US20080311058A1 (en) * 2007-06-18 2008-12-18 Connopco, Inc., D/B/A Unilever Stable high internal phase emulsions and compositions comprising the same
MX2010002592A (es) * 2007-09-10 2010-03-30 Glenmark Pharmaceuticals Ltd Composicion farmaceutica topica para la combinacion de acido fusidico y corticoesteroides.
US20090082318A1 (en) * 2007-09-26 2009-03-26 Protia, Llc Deuterium-enriched mometasone
WO2010048675A1 (en) * 2008-10-30 2010-05-06 Ego Pharmaceuticals Pty Ltd Anti-inflammatory pharmaceutical compositions comprising a corticosteroid, hexylene glycol and water
SI2429510T1 (sl) 2009-05-12 2015-10-30 Galenica Ab Emulzija olja v vodi mometazona in propilen glikola
EP2394653A1 (en) 2010-05-26 2011-12-14 Almirall, S.A. Topical pharmaceutical compositions comprising mometasone furoate
US20110305649A1 (en) * 2010-06-14 2011-12-15 Conopco, Inc., D/B/A Unilever High Humectant High Internal Phase Emulsion
US8821839B2 (en) 2010-10-22 2014-09-02 Conopco, Inc. Compositions and methods for imparting a sunless tan with a vicinal diamine
US8398959B2 (en) 2010-12-06 2013-03-19 Conopco, Inc. Compositions and methods for imparting a sunless tan with functionalized adjuvants
US8961942B2 (en) 2011-12-13 2015-02-24 Conopco, Inc. Sunless tanning compositions with adjuvants comprising sulfur comprising moieties
RU2548764C2 (ru) * 2013-01-25 2015-04-20 Открытое Акционерное Общество "Татхимфармпрепараты" Лекарственное средство для лечения дерматозов (варианты)
US9744122B2 (en) * 2013-04-29 2017-08-29 Helene Bertrand Topical formulation for pain relief
JP2015196663A (ja) * 2014-04-01 2015-11-09 ロレアル ナノ又はマイクロエマルションの形態の組成物
FR3039399B1 (fr) * 2015-07-31 2018-08-24 Idl International Drug Licensing Creme pour l'admnistration de steroides et son procede de preparation
JP6982293B2 (ja) * 2017-07-25 2021-12-17 株式会社大阪製薬 皮膚外用組成物
CA3191886A1 (en) * 2020-08-20 2022-02-24 Pfizer Inc. Stable topical formulations of 1(r)-4-(5-(4-methoxy-3-propoxyphenyl)pyridin-3-yl)-1,2-oxaborolan-2-ol

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4048310A (en) * 1976-02-24 1977-09-13 E. R. Squibb & Sons, Inc. Topical steroid formulation in form of lotion or cream
US4070462A (en) * 1976-10-26 1978-01-24 Schering Corporation Steroid ointment
US4124707A (en) * 1976-12-22 1978-11-07 Schering Corporation 7α-Halogeno-3,20-dioxo-1,4-pregnadienes, methods for their manufacture, their use as anti-inflammatory agents, and pharmaceutical formulations useful therefor
US4083974A (en) * 1977-03-07 1978-04-11 The Upjohn Company Topical steroidal anti-inflammatory preparations containing polyoxypropylene 15 stearyl ether
US4201778A (en) * 1977-11-08 1980-05-06 Schering Corporation 6-Acyloxy-1,4,6-pregnatrienes, their use as anti-inflammatory agents, methods for their manufacture, and 6-oxo-1,4-pregnadiene intermediates
US4267173A (en) * 1979-11-05 1981-05-12 Schering Corporation Use of 6β-fluoro-7α-halogenocorticoids as topical anti-inflammatories and pharmaceutical formulations useful therefor
ATE8790T1 (de) * 1981-02-02 1984-08-15 Schering Corporation Aromatische heterocyclische steroidester, verfahren zu ihrer herstellung und pharmazeutische zusammensetzungen, die sie enthalten.
JPS59137408A (ja) * 1983-01-27 1984-08-07 Taisho Pharmaceut Co Ltd 軟膏
US4489071A (en) * 1983-12-09 1984-12-18 Schering Corporation Betamethasone dipropionate cream

Also Published As

Publication number Publication date
IL84055A0 (en) 1988-03-31
MX9203395A (es) 1992-07-01
GR3002086T3 (en) 1992-12-30
EP0318522A1 (en) 1989-06-07
FI100047B (fi) 1997-09-15
WO1988002257A1 (en) 1988-04-07
DK295088D0 (da) 1988-05-31
ATE62815T1 (de) 1991-05-15
JPH02500976A (ja) 1990-04-05
KR880701555A (ko) 1988-11-03
FI891552A0 (fi) 1989-03-31
IE872633L (en) 1988-04-02
DK295088A (da) 1988-05-31
AU603837B2 (en) 1990-11-29
CA1294877C (en) 1992-01-28
ZA877401B (en) 1988-05-25
EP0262681A1 (en) 1988-04-06
DE3769568D1 (de) 1991-05-29
PH23440A (en) 1989-08-07
ES2038643T3 (es) 1993-08-01
AU8071287A (en) 1988-04-21
DK174790B1 (da) 2003-11-17
NO175350B (no) 1994-06-27
FI891552A (fi) 1989-03-31
JPH0643317B2 (ja) 1994-06-08
OA09034A (en) 1991-03-31
IE60492B1 (en) 1994-07-27
HK102593A (en) 1993-10-08
EP0262681B1 (en) 1991-04-24
NO882417L (no) 1988-06-01
NZ222020A (en) 1990-03-27
IL84055A (en) 1991-09-16
NO882417D0 (no) 1988-06-01
US4808610A (en) 1989-02-28
KR930010585B1 (ko) 1993-10-30

Similar Documents

Publication Publication Date Title
NO175350C (no) Fremgangsmåte for fremstilling av et topisk krempreparat for behandling av betennelse
EP0206291A3 (en) Sprayable pharmaceutical preparation for topical application
PT77016A (en) Process for the preparation of topical anti-inflammatory compositions containing pyroxycame as active ingredient
DE3579128D1 (de) 13-cis-vitamin-a-saeure als wirksubstanz enthaltende arzneimittel.
ZA794371B (en) Acid addition salts of 16 beta -monoquaternary ammonium derivatives of 2 beta,16 beta-bis-piperidino-androstanes and pharmaceutical preparations containing same
IL52227A (en) Process for the preparation of 10,19-dihydro-vitamin d derivatives and some novel 10,19-dihydro-1alpha-hydroxy and 1 alpha,25-dihydroxy-vitamin d3 compounds and pharmaceutical compositions containing them
IT7825221A0 (it) Derivati dell'acido aminobenzoico, procedimento per la loro preparazione e prodotti medicinali contenenti tali derivati dell'acido aminobenzoico.
FR2321294A1 (fr) Derives d'acides 7b-amino-3-cephem-3-carbonylmethyl-4-carboxyliques utiles comme medicaments
IE810891L (en) Topical formulation
IT1228437B (it) "derivati di 2,3,4,5,6,7 esaidro 2,7-metano-1,5 benzossazonina (rispettivamente 1,4 benzossazonina), procedimento per la loro preparazione e prodotti medicinali che contengono questi composti.
NO164243C (no) Analogifremgangsmaate for fremstilling av nye terapeutisk aktive 16,17-acetalsubstituerte pregnan-21-oinsyrederivater
IT8024152A0 (it) Derivati dell'1,1,2-trifenilpropano e dell'1,1,2-trifenilpropene, procedimento per la loro preparazione e composizioni farmaceutiche contenenti i composti
DE3372772D1 (en) Quinazolinone derivatives, process for their preparation and their use in medicaments
MY100547A (en) Betamethasone dipropionate cream
IT8048738A0 (it) Formulazione di corticosteroidi a bastoncino per il trattamento topico di dermatiti
LU81501A1 (fr) Compositions pharmaceutiques comprenant de la trimethoprime,ainsi que des derives d'acides n-ethyl-gamma-pyridone-3-carboxyliques
IT7947594A0 (it) Procedimento per la preparazione di derivati di acido 1,5-ciclo-esadiencarbossilico sostituito e prodotto ottenuto
IL53549A (en) Process for the preparation of 1-aziridine-carboxylic acid ester derivatives,pharmaceutical compositions containing the same and certain such novel compounds
NZ189211A (en) 1,4-cyclohexadiene carboxylic acid derivatives and pharmaceutical compositions
SE7902817L (sv) Substituerade /4h/ 1,3-bensodioxin-2-karboxylsyraderivat, framstellning och anvendning derav sasom lekemedel samt farmaceutiska kompositioner innehallande dessa
DE2965783D1 (en) Monochlorcitric acid derivatives, pharmaceutical compositions containing them and process for the preparation of these derivatives
GB1418019A (en) Antimicrobial compositions
IT7823614A0 (it) Composizioni farmaceutiche contenenti derivati dell'acido mercapto-acetico.
IT8222843A0 (it) Derivati dell'acido 5-tiazolil-acetico, procedimento per la loro preparazione e composizioni farmaceutiche contenenti tali derivati.
IT8222845A0 (it) Tioesteri di derivati dell'acido 5-tiazolil acetico, procedimento per la loro preparazione e composizioni farmaceutiche contenenti tali tioesteri.